EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Health-related quality of life in non-alcoholic fatty liver disease: A cross-cultural study between Spain and the United Kingdom

Jesús Funuyet-Salas iD, Agustín Martín-Rodríguez, María Ángeles Pérez-San-Gregorio, Luke Vale, Tomos Robinson, Quentin M Anstee, Manuel Romero-Gómez

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0300362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Jesús Funuyet-Salas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, Loyola University, Seville, Spain. Hauptthemen laut MEDLINE: Quality of Life, Non-alcoholic Fatty Liver Disease, Cross-Cultural Comparison. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS) consortium, Innovative Medicines Initiative (IMI2) Program of the European Union, EU Horizon 2020 programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

It is unclear what biopsychosocial factors influence the impact of NAFLD on health-related quality of life (HRQoL), and if these factors are equally important predictors between different nationalities.

Methods

HRQoL (CLDQ) was measured in both Southern European (Spain, n = 513) and Northern European (United Kingdom -UK-, n = 224) cohorts of patients with NAFLD in this cross-sectional study. For each cohort, participant data were recorded on histological grade of steatohepatitis, stage of fibrosis and biopsychosocial variables. Regression analysis was used to explore which of these variables predicted HRQoL. Moderated mediation models were conducted using SPSS PROCESS v3.5 macro.

Results

Participants with severe fibrosis reported more fatigue, systemic symptoms and worry, and lower HRQoL than those with none/mild fibrosis, regardless of place of origin. In addition, body mass index (BMI) and gender were found to be significant predictors of HRQoL in both Spanish and UK participants. Female gender was associated with worse emotional function, higher BMI and more fatigue, which predicted lower participants’ HRQoL. UK participants showed more systemic symptoms and worry than Spanish participants, regardless of liver severity. The negative effects of gender on HRQoL through emotional function, BMI and fatigue were reported to a greater degree in UK than in Spanish participants.

Conclusions

UK participants showed a greater impairment in HRQoL as compared to Spanish participants. Higher fibrosis stage predicted lower HRQoL, mainly in the Spanish cohort. Factors such as female gender or higher BMI contributed to the impact on HRQoL in both cohorts of patients and should be considered in future multinational intervention studies in NAFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeNon-alcoholic Fatty Liver DiseaseCross-Cultural ComparisonHumansMaleUnited KingdomFemaleSpainMiddle AgedCross-Sectional StudiesAdultBody Mass IndexFatigue

Autor:innen und Institutionen

  • Department of Psychology, Loyola University, Seville, Spain.
  • Faculty of Psychology, Department of Personality, Assessment, and Psychological Treatment, University of Seville, Seville, Spain.
  • Faculty of Medical Sciences, Population Health Sciences Institute, Health Economics Group, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • National Institute for Health Research (NIHR) Newcastle In Vitro Diagnostics Co-Operative and NIHR Applied Research Collaboration North East and North Cumbria, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Faculty of Medical Sciences, Translational & Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Newcastle NIHR Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, United Kingdom.

ORCID-Profile: Jesús Funuyet-Salas

Förderung

  • Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS) consortium
  • Innovative Medicines Initiative (IMI2) Program of the European Union
  • EU Horizon 2020 programme
  • European Federation of Pharmaceutical Industries and Associations
  • The European NAFLD Registry
  • Newcastle NIHR Biomedical Research Centre
  • Fondo Europeo de Desarrollo Regional (FEDER)/Ministerio de Ciencia e Innovación—Agencia Estatal de Investigación
  • Ministerio de Educación y Formación Profesional

Zitieren

APA

Funuyet-Salas, J., Martín-Rodríguez, A., Pérez-San-Gregorio, M. Á., Vale, L., Robinson, T., Anstee, Q. M., & Romero-Gómez, M. (2024). Health-related quality of life in non-alcoholic fatty liver disease: A cross-cultural study between Spain and the United Kingdom. PLOS ONE. https://doi.org/10.1371/journal.pone.0300362

Vancouver

Funuyet-Salas J, Martín-Rodríguez A, Pérez-San-Gregorio MÁ, Vale L, Robinson T, Anstee QM, et al. Health-related quality of life in non-alcoholic fatty liver disease: A cross-cultural study between Spain and the United Kingdom. PLOS ONE. 2024. doi:10.1371/journal.pone.0300362

BibTeX
@article{FunuyetSalas2024,
  author = {Funuyet-Salas, Jesús and Martín-Rodríguez, Agustín and Pérez-San-Gregorio, María Ángeles and Vale, Luke and Robinson, Tomos and Anstee, Quentin M and Romero-Gómez, Manuel},
  title = {Health-related quality of life in non-alcoholic fatty liver disease: A cross-cultural study between Spain and the United Kingdom},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0300362}
}
Kostenlos starten →